Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis

Control of cutaneous leishmaniasis (CL) in the Americas is dependent on chemotherapy with parenteral pentavalent antimonials. High rates of treatment failure urge the search for predictive and prognostic markers of therapeutic responsiveness. In this study, we aimed to identify biomarkers of therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Deninson Alejandro, Prieto, Miguel Dario, Martínez-Valencia, Alvaro José, Cossio, Alexandra, Burgess, Karl E. V., Burchmore, Richard J.S., Gómez, María Adelaida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595045/
https://www.ncbi.nlm.nih.gov/pubmed/31281253
http://dx.doi.org/10.3389/fphar.2019.00657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595045/
https://www.ncbi.nlm.nih.gov/pubmed/31281253
http://dx.doi.org/10.3389/fphar.2019.00657

Ejemplares similares